Table 2. Management, outcomes, and secondary prevention of heart failure associated with PPCM and COVID-19.
This table shows that even though managing PPCM and COVID-19-associated heart failure may overlap, both still have differences in the management, outcome, and ways to prevent them.
PPCM: peripartum cardiomyopathy; HF: heart failure.
| PPCM | COVID-19-associated HF | |
| Management | High threshold for cardiac devices, possible need for emergent delivery | COVID-19-specific therapy if in the window |
| Outcome | High chance of partial or full recovery | Appears variable; more data needed |
| Future targeted treatment/prevention | Bromocriptine? Counseling on future pregnancies | Vaccination |